Long proclaimed as one of the U.S. sectors most ripe for private equity investment, given its growth prospects as well as its relatively fragmented nature, healthcare services saw a decade high of 203 completed buyouts in 2015. Total deal value also surged after staying relatively flat for three years, although it did not come close to 2011 numbers, in a sign more of buyer caution around elevated multiples and a focus on the core and lower middle market than anything else.

The elevated investment count testifies to how active PE firms have been in rolling up providers in the core and lower middle market by enterprise size, consolidating across verticals and geographies in order to scale efficiencies. Through such adding on, PE buyers can also mitigate fairly high initial purchase multiples, further sweetening the appeal of buying up provider practices. Given the depth and breadth of the U.S. healthcare provider network, PE buyout flow in the space should remain fairly strong in 2016, although perhaps not at quite the same height as more and more firms flock to the space in hopes of building out healthcare platforms and competition, as well as costs, stymie activity somewhat. M&A in healthcare on the whole should continue apace as chains seek more efficiency across different provider and population segments, offering potential exit avenues for PE sponsors. That should help maintain robust selling off of PE-backed holdings throughout all of next year.
Latest news
Lack of new issues clouds CLO market
It’s been boom time in the leveraged loan market but now that market has eased off, what are the implications…
Multiples on PE buyouts
This quarter marks our integration of SPI by StepStone as the primary source for US buyout valuation metrics for the PE Breakdown.
US Leveraged Loan Issuance Slows to $76.5b in July
The US leveraged loan market has continued to slow from the May level of $104.7b, with approximately $76.5b priced in…